Clinical Trial: Efficacy of Tranexamic Acid In Reducing Blood Loss During Cesarean Section Because Of Placenta Previa

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Efficacy of Tranexamic Acid In Reducing Blood Loss Among Pregnant Women During Cesarean Section Because Of Placenta Previa

Brief Summary: This study evaluate role of tranexamic acid in reducing blood loss among pregnant women undergoing cesarean section because of placenta previa .Half of participants will receive tranexamia acid drug While the other half will receive placebo.

Detailed Summary:

Tranexamic Acid used in the field of obstetrics to decrease blood loss during and after cesarean section .

Tranexamic Acid is an antifibrinolytic agent which cause reversible and competitive blockade of the lysine binding sites in plasminogen molecules . It is a synthetic analog of amino acid lysine and its action is to reduce blood loss

Sponsor: Medical Research Council

Current Primary Outcome: Amount of Actual blood loss in each group [ Time Frame: 6hour after operation ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Difference in haemoglobin before operation and 24 hours after operation [ Time Frame: 24 hours ]

Original Secondary Outcome: Same as current

Information By: Medical Research Council

Dates:
Date Received: February 17, 2016
Date Started: August 2015
Date Completion:
Last Updated: February 17, 2016
Last Verified: February 2016